Showing 15,481 - 15,500 results of 15,769 for search '"immunosuppression"', query time: 0.18s Refine Results
  1. 15481

    Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability by Qi Zhang, Jiangchao Wu, Tingbo Liang, Xueli Bai, Xun Wang, Jianpeng Sheng, Junlei Zhang, Jianghui Tang, Jinyuan Song, Yongtao Ji

    Published 2023-02-01
    “…Background Solid tumors pose unique roadblocks to treatment with chimeric antigen receptor (CAR) T cells, including limited T-cell persistence, inefficient tumor infiltration, and an immunosuppressive tumor microenvironment. To date, attempts to overcome these roadblocks have been unsatisfactory. …”
    Get full text
    Article
  2. 15482

    Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease—A Multi-Centre Cross-Sectional Study by Aleksandra Glapa-Nowak, Mariusz Szczepanik, Jarosław Kwiecień, Anna Szaflarska-Popławska, Anna Flak-Wancerz, Barbara Iwańczak, Marcin Osiecki, Jarosław Kierkuś, Tomasz Pytrus, Dariusz Lebensztejn, Tomasz Banasiewicz, Aleksandra Banaszkiewicz, Jarosław Walkowiak

    Published 2020-12-01
    “…Patients diagnosed in winter were significantly younger at diagnosis (11.4 vs. 13.0; <i>p</i><sub>adj</sub> = 0.0180) and first immunosuppressive treatment (11.3 vs. 13.3; <i>p</i><sub>adj</sub> = 0.0109) than those diagnosed in other seasons. …”
    Get full text
    Article
  3. 15483

    FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation by Alexis Yero, Tao Shi, Jean-Pierre Routy, Jean-Pierre Routy, Cécile Tremblay, Cécile Tremblay, Madeleine Durand, Cecilia T. Costiniuk, Cecilia T. Costiniuk, Mohammad-Ali Jenabian, Mohammad-Ali Jenabian

    Published 2022-07-01
    “…FoxP3+ CD8 T-cells in untreated participants expressed higher levels of immunosuppressive LAP(TGF-β1) and CD39 than uninfected controls, whereas early ART did not affect their expression. …”
    Get full text
    Article
  4. 15484

    Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis by C. Caruso, L. Laterza, C. R. Settanni, S. Colantuono, C. Di Mario, B. Tolusso, F. Castrì, E. Gremese, E. Gremese, F. Scaldaferri, F. Scaldaferri, A. Armuzzi, A. Armuzzi, C. De Simone, K. Peris, A. Chiricozzi, A. Gasbarrini, A. Gasbarrini, A. Gasbarrini

    Published 2023-01-01
    “…In consideration of the poor response to conventional immunosuppressants and the presence of type 2 inflammatory manifestations, treatment with dupilumab at an initial dose of 600 mg, followed by a maintenance dose of 300 mg every other week, according to atopic dermatitis labeled dose, was started and combined to oral budesonide 6 mg/day and 6-mercaptopurine 75 mg/day. …”
    Get full text
    Article
  5. 15485

    Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients by Job J. Engel, Caspar I. van der Made, Nick Keur, Todia Setiabudiawan, Rutger J. Röring, Georgia Damoraki, Helga Dijkstra, Heidi Lemmers, Sofia Ioannou, Garyfallia Poulakou, Jos W. M. van der Meer, Evangelos J. Giamarellos-Bourboulis, Vinod Kumar, Vinod Kumar, Frank L. van de Veerdonk, Mihai G. Netea, Mihai G. Netea, Athanasios Ziogas

    Published 2023-08-01
    “…Although its broad immunosuppressive effects are well-described, the immunological mechanisms modulated by dexamethasone in patients hospitalized with COVID-19 remain to be elucidated.ObjectiveWe combined functional immunological assays and an omics-based approach to investigate the in vitro and in vivo effects of dexamethasone in the plasma and peripheral blood mononuclear cells (PBMCs) of COVID-19 patients.MethodsHospitalized COVID-19 patients eligible for dexamethasone therapy were recruited from the general care ward between February and July, 2021. …”
    Get full text
    Article
  6. 15486

    The impact of multifactorial factors on the Quality of Life of Behçet's patients over 10 years by Amal A. Senusi, Amal A. Senusi, John Mather, Dennis Ola, Dennis Ola, Lesley A. Bergmeier, Lesley A. Bergmeier, Bindi Gokani, Farida Fortune, Farida Fortune

    Published 2022-12-01
    “…The 2014 and 2020 surveys reported the QoL is significantly better in patients on immunosuppressant, who did sport, continued in employment and not receiving benefits.ConclusionJoints and neurological symptoms are the main symptoms which had negative impact on BS patients over the 10 years, sociodemographic (gender, age, marital, and education status), lifestyle (medication, cannabis, drinking wine, and regular exercise), employment status (employee and no career change), and accessing benefits (never claim benefit) had significant influence on patients' HRQoL.…”
    Get full text
    Article
  7. 15487

    Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population by Xin-Hui Khoo, Shin Yee Wong, Nik Razima Wan Ibrahim, Ruey Terng Ng, Kee Seang Chew, Way Seah Lee, Zhi Qin Wong, Raja Affend Raja Ali, Shahreedhan Shahrani, Alex Hwong-Ruey Leow, Ida Normiha Hilmi, Ida Normiha Hilmi

    Published 2022-08-01
    “…Background and AimsThiopurines, which are immunosuppressive drugs for maintaining remission for inflammatory bowel disease, are known to cause myelotoxicity in patients with Nudix Hydroxylase 15 (NUDT15) genetic variants in some Asian countries with monoethnic populations. …”
    Get full text
    Article
  8. 15488

    Natural products, including a new caboxamycin, from Streptomyces and other Actinobacteria isolated in Spain from storm clouds transported by Northern winds of Arctic origin by Aida Sarmiento-Vizcaíno, Aida Sarmiento-Vizcaíno, Aida Sarmiento-Vizcaíno, Jesús Martín, Francisco Javier Ortiz-López, Fernando Reyes, Luis A. García, Gloria Blanco, Gloria Blanco, Gloria Blanco

    Published 2022-11-01
    “…Comparative analyses with natural products databases allowed the identification of 69 structurally diverse natural products with contrasted biological activities, mostly as antibiotics and antitumor agents, but also anti-inflammatory, antiviral, antiparasitic, immunosuppressant and neuroprotective among others. The molecular formulae of the 25 remaining compounds were determined by HRMS. …”
    Get full text
    Article
  9. 15489

    Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy by Gang Zhou, David H Munn, Zhi-Chun Ding, Marco L Davila, Hongyan Xu, Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, Md Yeashin Gazi, Gregory Gorman, Roni Bollag, Locke J Bryan, Gary A Piazza

    Published 2022-07-01
    “…Moreover, the beneficial effect of indo in ACT did not rely on its inhibitory effect on the immunosuppressive cyclooxygenase 2 (COX2)/prostaglandin E2 (PGE2) axis. …”
    Get full text
    Article
  10. 15490

    Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors by Xin‐Yu Chen, Bin Li, Ye Wang, Juan Jin, Yu Yang, Lei‐Huan Huang, Meng‐Di Yang, Jian Zhang, Bi‐Yun Wang, Zhi‐Ming Shao, Ting Ni, Sheng‐Lin Huang, Xi‐Chun Hu, Zhong‐Hua Tao

    Published 2023-09-01
    “…Low ARID1A expression in TNBC, causing an immunosuppressive microenvironment, promoted AIR and inhibited CD8+ T cell infiltration and activity through upregulating PD‐L1. …”
    Get full text
    Article
  11. 15491

    A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma by Zhou Jiang, Yongzhong Luo, Lemeng Zhang, Haitao Li, Changqie Pan, Hua Yang, Tianli Cheng, Jianhua Chen

    Published 2022-07-01
    “…Recently, it was found that lactate acid accumulation induced an immunosuppressive microenvironment. However, these results were based on a single gene and it was unclear that lactate acid genes were associated with immunotherapy and able to predict overall survival. …”
    Get full text
    Article
  12. 15492

    Fetal Muse-based therapy prevents lethal radio-induced gastrointestinal syndrome by intestinal regeneration by Honorine Dushime, Stéphanie G. Moreno, Christine Linard, Annie Adrait, Yohann Couté, Juliette Peltzer, Sébastien Messiaen, Claire Torres, Lydia Bensemmane, Daniel Lewandowski, Paul-Henri Romeo, Vanessa Petit, Nathalie Gault

    Published 2023-08-01
    “…Under gas anesthesia, GIS mice were treated or not through an intravenous retro-orbital injection of 50,000 WJ-Muse, freshly isolated or cryopreserved, shortly after an 18 Gy-abdominal IR. No immunosuppressant was delivered to the mice. Mice were euthanized either 24 h post-IR to assess early small intestine tissue response, or 7 days post-IR to assess any regenerative response. …”
    Get full text
    Article
  13. 15493
  14. 15494

    Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observation... by Joseph Miller, Stephen Guy, Alun Pope, Emogene Aldridge, Paul Buntine, Fang Qi (Alex) Wong, Hannah McDonald, Mania Ahmed, Kang Hui Teow, Morgan Roney, Farzaneh Mohammadi, Liam Hackett, Susanna Jenner, Belinda Davis

    Published 2022-12-01
    “…Patients meeting any of the following criteria were excluded: &lt;16 years of age; acute respiratory symptom(s) with onset&gt;14 days prior to testing; current immunosuppressive or interferon therapy; live immunisation within the last 30 days; fever lasting&gt;7 days; antibiotic or antiviral use in the preceding 14 days; experience of major trauma, major surgical intervention or severe burns within the last 30 days.Primary and secondary outcome measures COVID-19 PCR results (detected, not detected) and FebriDx results (bacterial positive, viral negative, viral positive).Results 94 participants were enrolled (female: 46; male: 48), 34% of participants (tested positive for COVID-19 according to PCR results, with a background incidence among all adult ED attenders of 2.5%. …”
    Get full text
    Article
  15. 15495
  16. 15496

    Endophthalmitis at a tertiary referral center: Characteristics and treatment outcomes over three decades by Wen-Fei Zhang, Wen-Fei Zhang, Xin-Yu Zhao, Xin-Yu Zhao, Li-Hui Meng, Li-Hui Meng, Huan Chen, Huan Chen, You-Xin Chen, You-Xin Chen

    Published 2022-08-01
    “…Patients with endogenous endophthalmitis were more likely to have binocular involvement; there were also more patients with diabetes mellitus or immunosuppressive diseases, and the prognosis of visual acuity (VA) was poorer. …”
    Get full text
    Article
  17. 15497

    UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer by Brittney S. Harrington, Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lidia F. Hernandez, Donna Butcher, Elijah F. Edmondson, Nadia Traficante, Joy Hendley, Australian Ovarian Cancer Study, Madeline Gough, Rebecca Rogers, Rohan Lourie, Jyoti Shetty, Bao Tran, Fathi Elloumi, Abdalla Abdelmaksoud, Madhu Lal Nag, Krystyna Mazan-Mamczarz, Carrie D. House, John D. Hooper, Christina M. Annunziata

    Published 2023-10-01
    “…Recurrence in EOC is driven by the survival of chemoresistant, stem-like tumor-initiating cells (TICs) that are supported by a complex extracellular matrix and immunosuppressive microenvironment. To target TICs to prevent recurrence, we identified genes critical for TIC viability from a whole genome siRNA screen. …”
    Get full text
    Article
  18. 15498

    Systemic Connective Tissue Disease and Neuromyelitis Optica Spectrum Disorder Coexistence: A Systematic Review and Meta-Analysis by Jessica Elisabetta Esposito, Giovanni Annoni, Milena D’Amato, Alessandra Graziosi, Francesca Troilo, Annalisa Di Risio, Gilda Angelini, Caterina Castiglione, Pierluigi Tocco, Paola Volpe, Giancarlo Di Iorio, Giustino Parruti, Ennio Polilli

    Published 2024-02-01
    “…These considerations should be taken into account in clinical experience of rheumatologists and neurologists, since early diagnosis of both conditions may influence the timing of immunosuppressive therapy and the prevention of systemic disabilities.…”
    Get full text
    Article
  19. 15499

    BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in<br /> Class 2 Uveal Melanomas by Christopher J. Kaler, James J. Dollar, Anthony M. Cruz, Jeffim N. Kuznetsoff, Margaret I. Sanchez, Christina L. Decatur, Jonathan D. Licht, Keiran S. M. Smalley, Zelia M. Correa, Stefan Kurtenbach, J. William Harbour

    Published 2022-07-01
    “…Using RNA sequencing (RNA-seq), we found that the most highly upregulated gene associated with BAP1 loss across these datasets was <i>PROS1</i>, which encodes a ligand that triggers phosphorylation and activation of the immunosuppressive macrophage receptor MERTK. The inverse association between <i>BAP1</i> and <i>PROS1</i> in class 2 UM was confirmed by single-cell RNA-seq, which also revealed that <i>MERTK</i> was upregulated in CD163+ macrophages in class 2 UM. …”
    Get full text
    Article
  20. 15500

    Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy by Xuan Wang, Jie Dai, Li Zhou, Xuefeng Xia, Xue Bai, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoting Wei, Xinan Sheng, Siming Li, Zhihong Chi, Lili Mao, Bin Lian, Xieqiao Yan, Yan Kong, Caili Li, Xuan Gao, Lirui Tang, Linzi Sun, Zhonghui Qi, Zelong Xu

    Published 2023-01-01
    “…Transcriptome analysis revealed that, compared with NEMM, PMME displayed more significant proliferation and inflammatory features with higher expression of genes related to antigen presentation and differentiation, and a less immunosuppressive signature with lower expression of inhibitory immune checkpoints and dedifferentiation-related genes. …”
    Get full text
    Article